We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Viasys to Acquire Ventilator Firm for $98 Million

By HospiMedica staff writers
Posted on 31 May 2005
Print article
In a move to extend the company's product line into the home care market, Viasys Healthcare, Inc. (Conshohocken, PA, USA) has agreed to acquire Pulmonetic Systems (Minneapolis, MN, USA) for an estimated U.S.$98 million in cash.

Pulmonetic Systems designs, manufactures, and markets portable mechanical ventilators for home health care. The company's LTV ventilator was the first commercially available mechanical ventilator to offer sophisticated respiratory modalities in a laptop-size device.
The LTV series is complemented by a comprehensive line of patient circuits, accessories, and options that meet the needs of both pediatric and adult patients. The company has annual revenues of around $42 million.

"The addition of Pulmonetic Systems to Viasys should accelerate our ability to address patient needs across the continuum of care by adding products and distribution to address home care and emergency medical services,” noted Randy Thurman, chairman, president, and CEO of Viasys. "This acquisition is consistent with our strategy of adding strategically valuable products, technologies, and distribution in the respiratory and neurological markets.”





Related Links:
Viasys
Pulmonetic Systems
Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Stereotactic QA Phantom
StereoPHAN
New
Instrument Table
Flexible and Rotatable 10-066

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.